---
figid: PMC2805793__10434_2009_766_Fig1_HTML
figlink: /pmc/articles/PMC2805793/figure/Fig1/
number: Fig. 1
caption: a Ligand binding and subsequent Erbb dimer formation initiates signaling
  through a complex array of intracellular pathways that initiate and control a range
  of cellular processes. Dimer formation results in the cross-phosphorylation of the
  dimer partners, creating docking sites that allow the recruitment of downstream
  signaling components and the formation of signaling complexes. Two key signaling
  pathways activated by the Erbb family dimers are the MAPK pathway, which stimulates
  proliferation, and the PI3K–Akt pathway, which promotes tumor cell survival (see
  the figure). Only signaling through these two pathways and some of the known outcomes
  are shown here for simplicity. b The antibody trastuzumab binds directly to domain
  IV of the extracellular region of ERBB2, suppressing ERBB2 signaling activity, preventing
  cleavage of the extracellular domain, and marking tumor cells that overexpress ERBB2
  for further immunological attack through antibody-dependent cell-mediated cytotoxicity.
  GSK3β, glycogen synthase kinase 3β; NF-κB, nuclear factor-κB; PDK1, pyruvate dehydrogenase
  kinase 1; PIP2, phosphatidylinositol biphosphate; PIP3, phosphatidylinositol triphosphate
pmcid: PMC2805793
papertitle: 'Targeting Gastric Cancer with Trastuzumab: New Clinical Practice and
  Innovative Developments to Overcome Resistance.'
reftext: Dimitrios H. Roukos. Ann Surg Oncol. 2010 Jan;17(1):14-17.
pmc_ranked_result_index: '38223'
pathway_score: 0.945776
filename: 10434_2009_766_Fig1_HTML.jpg
figtitle: Ligand binding and subsequent Erbb dimer formation initiates signaling through
  a complex array of intracellular pathways that initiate and control a range of cellular
  processes
year: '2010'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2805793__10434_2009_766_Fig1_HTML.html
  '@type': Dataset
  description: a Ligand binding and subsequent Erbb dimer formation initiates signaling
    through a complex array of intracellular pathways that initiate and control a
    range of cellular processes. Dimer formation results in the cross-phosphorylation
    of the dimer partners, creating docking sites that allow the recruitment of downstream
    signaling components and the formation of signaling complexes. Two key signaling
    pathways activated by the Erbb family dimers are the MAPK pathway, which stimulates
    proliferation, and the PI3K–Akt pathway, which promotes tumor cell survival (see
    the figure). Only signaling through these two pathways and some of the known outcomes
    are shown here for simplicity. b The antibody trastuzumab binds directly to domain
    IV of the extracellular region of ERBB2, suppressing ERBB2 signaling activity,
    preventing cleavage of the extracellular domain, and marking tumor cells that
    overexpress ERBB2 for further immunological attack through antibody-dependent
    cell-mediated cytotoxicity. GSK3β, glycogen synthase kinase 3β; NF-κB, nuclear
    factor-κB; PDK1, pyruvate dehydrogenase kinase 1; PIP2, phosphatidylinositol biphosphate;
    PIP3, phosphatidylinositol triphosphate
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK11
  - MAPK8
  - NFKB1
  - SHC3
  - KRAS
  - SHC2
  - MAPK14
  - MAPK1
  - MAPK9
  - NRAS
  - MAPK10
  - MAPK3
  - GSK3B
  - BRAF
  - PIK3R6
  - PIK3R5
  - SHC4
  - PIK3CA
  - SOS2
  - BAD
  - GRB2
  - HRAS
  - RAF1
  - MAPK12
  - ERBB2
  - ERBB3
  - KIDINS220
  - ARAF
  - MAP2K1
  - PIK3CB
  - MTOR
  - MAPK13
  - SOS1
  - MAP2K2
  - PIK3R3
  - PTEN
  - SHC1
  - PIK3CG
  - PIK3CD
  - PIK3R4
  - Tyrosine
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: ERBB2
  symbol: ERBB2
  source: hgnc_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: ERBB3
  symbol: ERBB3
  source: hgnc_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: arms
  symbol: ARMS
  source: hgnc_alias_symbol
  hgnc_symbol: KIDINS220
  entrez: '57498'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
chemicals:
- word: Tyrosine
  source: MESH
  identifier: D014443
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
